Cleveland BioLabs cbiolabs.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Cleveland BioLabs (NASDAQ: CBLI) is a biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. The company's proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. Cleveland BioLabs combines proven scientific expertise and depth of knowledge about products' mechanisms of action into a passion for developing drugs to save lives.

Cleveland BioLabs (NASDAQ: CBLI) is a biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. The company's proprietary platform of toll-like immune receptor activators has applications i...Show all

Company (Alive / Active)

Phone: 716-849-6810

Fax:

73 High Street

Buffalo, 14203
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cleveland BioLabs $36M Mar 16, 2007

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cleveland BioLabs Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 21 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of protecting against apoptosis using lipopeptides Mar 06, 2015 Jul 05, 2016 Patent
Use of toll-like receptor agonist for treating cancer Jan 10, 2012 Jun 28, 2016 Patent
Methods for treating tourniquet-induced injuries Nov 22, 2013 Apr 14, 2015 Patent
Methods of protecting against apoptosis using lipopeptides Jul 15, 2013 Apr 14, 2015 Patent
Methods for treating reperfusion injuries using flagellin Jun 22, 2012 Dec 31, 2013 Patent
See all 19 patents